Browsing Centre for Biochemical Pharmacology by Author "Vik, A"
Now showing items 1-5 of 5
-
PCn-3 DPA Pathway Regulates Human Monocyte Differentiation and Macrophage Function
Pistorius, K; Souza, PR; De Matteis, R; Austin-Williams, S; Primdahl, KG; Vik, A; Mazzacuva, F; Colas, RA; Marques, RM; Hansen, TV (2018-06-21) -
Recent advances in the chemistry and biology of anti-inflammatory and specialized pro-resolving mediators biosynthesized from n-3 docosapentaenoic acid
Vik, A; Dalli, J; Hansen, TV (2017-06-01) -
Resolving Inflammation: Synthesis, Configurational Assignment, and Biological Evaluations of RvD1n-3 DPA.
Tungen, JE; Gerstmann, L; Vik, A; De Matteis, R; Colas, RA; Dalli, J; Chiang, N; Serhan, CN; Kalesse, M; Hansen, TV (2018-12-04)New drugs that can resolve inflammation without immunosuppressive effects are at the medicinal chemistry frontier. Pro-resolving endogenously formed small molecules, that is, the resolvins, are excellent candidates displaying ... -
Stereocontrolled synthesis and investigation of the biosynthetic transformations of 16(S),17(S)-epoxy-PDn-3 DPA.
Primdahl, KG; Tungen, JE; De Souza, PRS; Colas, RA; Dalli, J; Hansen, TV; Vik, A (2017-10-18)PD1n-3 DPA is a specialized pro-resolving lipid mediator that displays potent anti-inflammatory properties and pro-resolving bioactivities. Such naturally occurring compounds are of current interest in biomolecular chemistry ... -
Synthesis of 13 (R)-Hyd roxy-7Z,10Z,13R,14E,16Z,19Z Docosapentaenoic Acid (13R-HDPA) and Its Biosynthetic Conversion to the 13-Series Resolvins
Primdahl, KG; Aursnes, M; Walker, ME; Colas, RA; Serhan, CN; Dalli, J; Hansen, TV; Vik, A (2016-10)